Volume | 15,519 |
|
|||||
News | - | ||||||
Day High | 24.12 | Low High |
|||||
Day Low | 23.805 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
Fidelity Disruptive Medicine ETF | FMED | NASDAQ | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
24.11 | 23.805 | 24.12 | 23.85 | 24.41 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
91 | 15,519 | 23.98 | 372,135 | - | 19.82 - 25.73 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
16:00:00 | 100 | 23.85 | USD |
Fidelity Disruptive Medicine ETF Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
50.65M | - | - | - | 34.29 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Fidelity Disruptive Medi...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
FMED Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 24.66 | 24.66 | 23.805 | 24.49 | 4,930 | -0.81 | -3.28% |
1 Month | 23.63 | 24.92 | 23.63 | 24.33 | 5,879 | 0.22 | 0.93% |
3 Months | 25.59 | 25.68 | 23.39 | 24.57 | 5,228 | -1.74 | -6.80% |
6 Months | 21.56 | 25.68 | 21.27 | 24.05 | 6,076 | 2.29 | 10.62% |
1 Year | 25.12 | 25.73 | 19.82 | 23.51 | 7,571 | -1.27 | -5.06% |
3 Years | 25.12 | 25.73 | 19.82 | 23.51 | 7,571 | -1.27 | -5.06% |
5 Years | 25.12 | 25.73 | 19.82 | 23.51 | 7,571 | -1.27 | -5.06% |
The investment seeks high total return through a combination of current income and capital appreciation. The fund normally invests at least 80% of the fund's assets in preferred securities and other income-producing securities. It normally invests in all types of preferred securities and other income-producing securities such as contingent convertible securities and corporate hybrid securities. The fund primarily invests in securities rated at least BB by S&P, Ba by Moodys, comparably rated by at least one nationally recognized credit rating agency, or, if unrated, considered by FMR to be of comparable quality. It is non-diversified. |